Guidance Document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100)

Health Canada has released their new guidance document for clinical trial researchers to comply with Part C, Div 5 of the Food & Drug Regulations. Review the document here.